Evidence map›Paper›PMID 31966530›Full record

ArticleInternational journal of clinical and experimental pathology2017

Platelet-rich plasma promotes cell viability of human hair dermal papilla cells (HHDPCs) in vitro.

Yuyan Wang, Liang Tang, Fei Zhu, Ming Jia

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Platelet-Rich Plasma in Androgenetic Alopecia.Indian dermatology online journal · 2021
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yuyan WangDepartment of Plastic Surgery, Hangzhou First People's Hospital, Nanjing Medical University Hangzhou, Zhejiang 310006, P.R China.
Liang TangDepartment of Plastic Surgery, Hangzhou First People's Hospital, Nanjing Medical University Hangzhou, Zhejiang 310006, P.R China.
Fei ZhuDepartment of Plastic Surgery, Hangzhou First People's Hospital, Nanjing Medical University Hangzhou, Zhejiang 310006, P.R China.
Ming JiaDepartment of Plastic Surgery, Hangzhou First People's Hospital, Nanjing Medical University Hangzhou, Zhejiang 310006, P.R China.
Hangzhou First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to clarify the effect of platelet-rich plasma (PRP) on human hair dermal papilla cell (HHDPC) viability and expression levels of alkaline phosphatase (ALP) and versican.

methodsEight healthy volunteers were enrolled, and different concentrations of PRP and platelet-poor plasma (PPP) were preparedby 2-step centrifugation method. HHDPCs were thencultivated. To identify the best incubating time of HHDPCs and plasmaconcentration, cell viability was investigated by MTT assays. In PRP- or PPP-treated HHDPCs, the mRNA levels of versican and ALP were checked by real-time quantitative PCR (qRT-PCR).

resultsBoth PRP (5% and 10%) and PPP (5% and 10%) could significantly promote cell viability of the HHDPCs (p4) in 72 h group, while the effect of 10% PRP on HHDPC viability was less than that of 5% PRP. qRT-PCR showed that PRP could significantly increase mRNA levels of ALP and versican in HHDPCs (p4) when compared with the control group. Meanwhile,Western blot indicated an obviously increased protein level of ALP and versican in PRP-treated HHDPCs (p4).

conclusionPRP could promote cell viability of HHDPCs. Besides, 5% PRP could significantly increase ALP and versican expression in both mRNA and protein levels in HHDPCs (p4).

Indexed as

human hair dermal papilla cellsMTT assayplatelet-poor plasmaPlatelet-rich plasma

Identifiers

PMID31966530
PMCPMC6966016
OpenAlexW3013254030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.